Trial Profile
Bioequivalence of ciclosporin formulations Neoral and Equoral in recipients of stem cell transplant recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2011
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Transplant rejection
- Focus Pharmacokinetics
- 01 Mar 2011 New trial record